A phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502367-37-00

Acronym

CAAA604A12101

Enrollment

Registered

2023-07-28

Start date

2024-11-29

Completion date

2024-12-13

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally advanced unresectable or metastatic gastroesophageal adenocarcinoma (GEA), Locally advanced unresectable or metastatic pancreatic ductal adenocarcinoma (PDAC), Recurrent glioblastoma multiforme (GBM)

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Italy, Netherlands, Spain

Outcome results